open access

Vol 11, Supp. C (2015)
suplement
Published online: 2015-05-29
Get Citation

Effective control of symptoms of advanced prostatic carcinoma — a case report of a patient treated with abiraterone acetate

Łukasz Głogowski

open access

Vol 11, Supp. C (2015)
suplement
Published online: 2015-05-29

Abstract

Prostatic carcinoma is one of the most common malignancies in men. Patients with castration resistant prostatic carcinoma are a group of a special concern. In that phase of the disease effective control of all symptoms is crucial. In the study, the case of a patient with CRPC treated with two lines of systemic therapy is presented. The therapy was well tolerated and the condition of a patient improved.

Abstract

Prostatic carcinoma is one of the most common malignancies in men. Patients with castration resistant prostatic carcinoma are a group of a special concern. In that phase of the disease effective control of all symptoms is crucial. In the study, the case of a patient with CRPC treated with two lines of systemic therapy is presented. The therapy was well tolerated and the condition of a patient improved.

Get Citation

Keywords

castration resistant prostatic carcinoma, docetaxel, abiraterone acete

About this article
Title

Effective control of symptoms of advanced prostatic carcinoma — a case report of a patient treated with abiraterone acetate

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. C (2015)

Published online

2015-05-29

Keywords

castration resistant prostatic carcinoma
docetaxel
abiraterone acete

Authors

Łukasz Głogowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl